HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomohiro Hirano Selected Research

immunosuppressive acidic protein

10/2016[Clinical Evaluation of Immunosuppressive Acidic Protein in the Serum of Patients with Locally Advanced Breast Cancer during Mohs Paste Treatment].
10/2005[Study of indoleamine 2,3-dioxygenase expression in patients with breast cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomohiro Hirano Research Topics

Disease

32Breast Neoplasms (Breast Cancer)
12/2020 - 10/2005
13Neoplasms (Cancer)
10/2018 - 10/2005
12Neoplasm Metastasis (Metastasis)
08/2021 - 10/2005
8Ductal Carcinoma
02/2019 - 11/2015
3Carcinoma (Carcinomatosis)
10/2018 - 11/2016
2Scirrhous Adenocarcinoma (Scirrhous Carcinoma)
12/2021 - 12/2020
2Neuroendocrine Carcinoma
04/2018 - 11/2017
2Lymphatic Metastasis
01/2018 - 11/2016
2Hemorrhage
10/2017 - 10/2016
2Thyroid Neoplasms (Thyroid Cancer)
11/2016 - 10/2015
1Stomach Neoplasms (Stomach Cancer)
12/2021
1Gastroparesis
12/2021
1Margins of Excision
12/2020
1Ulcer
02/2018
1Lobular Carcinoma
01/2018
1Pleural Effusion (Pleural Effusions)
10/2017
1Obesity
10/2016
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
11/2014
1Noninfiltrating Intraductal Carcinoma (DCIS)
11/2013

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
12/2021 - 11/2013
11Progesterone Receptors (Progesterone Receptor)IBA
12/2018 - 11/2013
10Estrogen ReceptorsIBA
12/2018 - 11/2013
9Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
10/2018 - 10/2005
4eribulinFDA Link
10/2018 - 11/2013
3Letrozole (Femara)FDA LinkGeneric
12/2020 - 02/2018
3Fulvestrant (Faslodex)FDA Link
01/2018 - 10/2016
2Hormones (Hormone)IBA
08/2021 - 10/2018
2Estrogens (Estrogen)FDA Link
04/2018 - 11/2013
2Bevacizumab (Avastin)FDA Link
02/2018 - 10/2017
2Aromatase InhibitorsIBA
10/2017 - 10/2014
2Paclitaxel (Taxol)FDA LinkGeneric
10/2017 - 11/2013
2Mohs' pasteIBA
10/2017 - 10/2016
2130-nm albumin-bound paclitaxelIBA
10/2017 - 11/2013
2Ointments (Pastes)IBA
10/2017 - 10/2016
2immunosuppressive acidic proteinIBA
10/2016 - 10/2005
1palbociclibIBA
10/2018
1Therapeutic UsesIBA
10/2018
1Chromogranin AIBA
04/2018
1SynaptophysinIBA
04/2018
1Epirubicin (Ellence)FDA LinkGeneric
10/2017
1taxaneIBA
10/2017
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2017
1lenvatinibIBA
11/2016
1C-Reactive ProteinIBA
10/2016
1Toremifene (Fareston)FDA Link
10/2014
1Epidermal Growth Factor (EGF)IBA
11/2013
1Lapatinib (GW572016)FDA Link
11/2012
1Trastuzumab (Herceptin)FDA Link
11/2012
1Immunoglobulin G (IgG)IBA
11/2011

Therapy/Procedure

12Therapeutics
10/2018 - 11/2013
7Drug Therapy (Chemotherapy)
10/2018 - 11/2013
5Segmental Mastectomy (Lumpectomy)
04/2019 - 11/2013
4Mastectomy (Mammectomy)
12/2020 - 01/2018
4Lymph Node Excision (Lymph Node Dissection)
04/2019 - 11/2016
2Palliative Care (Palliative Therapy)
10/2017 - 10/2016
2Neoadjuvant Therapy
10/2015 - 11/2013
1Gastrectomy
12/2021
1Immunotherapy
11/2011